HCID 66687731, Verbindung → 1-[5-[3-Bromo-5-(trifluoromethoxy)phenyl]-1-(6-methyl-3-pyridyl)pyrazole-3-carbonyl]imidazolidin-4-one
Reaktionsgleichung
[Br:1][C:2]1[CH:3]=[C:4]([C:13]2[N:17]([C:18]3[CH:19]=[N:20][C:21]([CH3:24])=[CH:22][CH:23]=3)[N:16]=[C:15]([C:25]([OH:27])=O)[CH:14]=2)[CH:5]=[C:6]([O:8][C:9]([F:12])([F:11])[F:10])[CH:7]=1.ClC1C=C(C2N(C3C=CC=CN=3)N=C(C([N:49]3[CH2:53][C:52](=[O:54])[NH:51][CH2:50]3)=O)C=2)C=C(F)C=1.Cl.N1C=CNC1=O>>[Br:1][C:2]1[CH:3]=[C:4]([C:13]2[N:17]([C:18]3[CH:19]=[N:20][C:21]([CH3:24])=[CH:22][CH:23]=3)[N:16]=[C:15]([C:25]([N:49]3[CH2:53][C:52](=[O:54])[NH:51][CH2:50]3)=[O:27])[CH:14]=2)[CH:5]=[C:6]([O:8][C:9]([F:10])([F:11])[F:12])[CH:7]=1Komponenten
4
Edukt 3
Produkt 1
Versuchsvorschrift
50 mg (0.11 mmol) of the compound of Example 41A is reacted analogously to the synthesis of the compound of Example 1 with 15 mg (0.13 mmol) of 4-imidazolinone-hydrochloride. 47 mg (81% of theory) of the title compound is obtained.